These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 33463473)

  • 1. Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels.
    Cook DC; Goldstein PA
    Curr Neuropharmacol; 2021; 19(11):1937-1951. PubMed ID: 33463473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpolarization-activated and cyclic nucleotide-gated channel proteins as emerging new targets in neuropathic pain.
    He JT; Li XY; Zhao X; Liu X
    Rev Neurosci; 2019 Jul; 30(6):639-649. PubMed ID: 30768426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCN channels as targets for drug discovery.
    Maher MP; Wu NT; Guo HQ; Dubin AE; Chaplan SR; Wickenden AD
    Comb Chem High Throughput Screen; 2009 Jan; 12(1):64-72. PubMed ID: 19149492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels.
    Young GT; Emery EC; Mooney ER; Tsantoulas C; McNaughton PA
    Pain; 2014 Sep; 155(9):1708-1719. PubMed ID: 24861581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
    Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
    Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.
    Wan Y
    Sheng Li Xue Bao; 2008 Oct; 60(5):579-80. PubMed ID: 18958363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-Gated Ion Channels in the PNS: Novel Therapies for Neuropathic Pain?
    Tibbs GR; Posson DJ; Goldstein PA
    Trends Pharmacol Sci; 2016 Jul; 37(7):522-542. PubMed ID: 27233519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperpolarization-activated cyclic-nucleotide-gated channels potentially modulate axonal excitability at different thresholds.
    Weerasinghe D; Menon P; Vucic S
    J Neurophysiol; 2017 Dec; 118(6):3044-3050. PubMed ID: 28904107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and pain.
    Dunlop J; Vasilyev D; Lu P; Cummons T; Bowlby MR
    Curr Pharm Des; 2009; 15(15):1767-72. PubMed ID: 19442189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.
    Tibbs GR; Rowley TJ; Sanford RL; Herold KF; Proekt A; Hemmings HC; Andersen OS; Goldstein PA; Flood PD
    J Pharmacol Exp Ther; 2013 Jun; 345(3):363-73. PubMed ID: 23549867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels.
    Shan Z; Cai S; Yu J; Zhang Z; Vallecillo TGM; Serafini MJ; Thomas AM; Pham NYN; Bellampalli SS; Moutal A; Zhou Y; Xu GB; Xu YM; Luo S; Patek M; Streicher JM; Gunatilaka AAL; Khanna R
    ACS Chem Neurosci; 2019 Jun; 10(6):2939-2955. PubMed ID: 30946560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCN2 ion channels: an emerging role as the pacemakers of pain.
    Emery EC; Young GT; McNaughton PA
    Trends Pharmacol Sci; 2012 Aug; 33(8):456-63. PubMed ID: 22613784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCN2 ion channels: basic science opens up possibilities for therapeutic intervention in neuropathic pain.
    Tsantoulas C; Mooney ER; McNaughton PA
    Biochem J; 2016 Sep; 473(18):2717-36. PubMed ID: 27621481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacemaking Activity in the Peripheral Nervous System: Physiology and Roles of Hyperpolarization Activated and Cyclic Nucleotide-Gated Channels in Neuropathic Pain.
    Liu F; Wuni GY; Bahuva R; Shafiq MA; Gattas BS; Ibetoh CN; Stratulat E; Gordon DK
    Cureus; 2020 Oct; 12(10):e11111. PubMed ID: 33240707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels as Drug Targets for Neurological Disorders.
    Santoro B; Shah MM
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():109-131. PubMed ID: 31914897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCN pacemaker channels and pain: a drug discovery perspective.
    Wickenden AD; Maher MP; Chaplan SR
    Curr Pharm Des; 2009; 15(18):2149-68. PubMed ID: 19519450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-PKA signaling is involved in regulation of spinal HCN channels function in diabetic neuropathic pain.
    Ma Y; Chen J; Yu D; Wei B; Jin H; Zeng J; Liu X
    Neurosci Lett; 2021 Apr; 750():135763. PubMed ID: 33617945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurophysiology of HCN channels: from cellular functions to multiple regulations.
    He C; Chen F; Li B; Hu Z
    Prog Neurobiol; 2014 Jan; 112():1-23. PubMed ID: 24184323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring HCN channels as novel drug targets.
    Postea O; Biel M
    Nat Rev Drug Discov; 2011 Nov; 10(12):903-14. PubMed ID: 22094868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-type voltage-gated calcium channels as targets for the development of novel pain therapies.
    Todorovic SM; Jevtovic-Todorovic V
    Br J Pharmacol; 2011 Jun; 163(3):484-95. PubMed ID: 21306582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.